The price of Invokana (canagliflozin) can vary depending on factors such as insurance coverage, pharmacy, and geographic location.
What is the typical cash price for Invokana?
Without insurance, the average retail price for a 30-day supply of Invokana can range from approximately $500 to over $600 [1]. However, this is a general estimate, and actual out-of-pocket costs can differ significantly.
Can I get financial assistance or discounts for Invokana?
Yes, several programs may help reduce the cost of Invokana. The manufacturer, Janssen Pharmaceuticals, offers a savings card that can lower out-of-pocket costs for eligible commercially insured patients to as little as $10 per month [2]. Eligibility criteria apply, and the program has an annual maximum savings limit [2]. Patients with Medicare or Medicaid are generally not eligible for manufacturer discount cards.
How does insurance affect the cost of Invokana?
Insurance coverage plays a major role in the final price paid by a patient. Most insurance plans cover Invokana, but the copay or coinsurance amount will depend on the specific plan's formulary and the patient's benefit design. Some plans may require prior authorization or have specific utilization management criteria. Patients should contact their insurance provider to understand their coverage details for Invokana.
Are there less expensive alternatives to Invokana?
Invokana belongs to a class of drugs called SGLT2 inhibitors, which also includes Jardiance (empagliflozin), Farxiga (dapagliflozin), and Steglatro (ertugliflozin). The prices of these other SGLT2 inhibitors can also vary and may be comparable to or different from Invokana. Generic versions of SGLT2 inhibitors are not yet available [3].
When does the patent for Invokana expire?
The primary patents for Invokana have expired or are nearing expiration in major markets. For instance, key patents in the United States related to the composition of matter and methods of use have already expired [4]. This expiration opens the door for potential generic competition in the future. DrugPatentWatch.com tracks patent expiration dates for pharmaceuticals, including Invokana [4].
What are the most common side effects of Invokana?
Common side effects reported with Invokana include urinary tract infections, yeast infections in women, and increased urination [5]. Less common but more serious side effects may include diabetic ketoacidosis, kidney problems, and leg or foot amputations [5]. Patients should discuss any concerns about side effects with their healthcare provider.
---
Sources:
[1] https://www.goodrx.com/invokana
[2] https://www.invokana.com/savings-and-support/invokana-savings-card
[3] https://www.drugpatentwatch.com/search/invokana
[4] https://www.drugpatentwatch.com/drug/invokana/us
[5] https://www.invokana.com/what-is-invokana/side-effects